Pular para o conteúdo
Merck
  • Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.

Allosteric inhibitors of Akt1 and Akt2: a naphthyridinone with efficacy in an A2780 tumor xenograft model.

Bioorganic & medicinal chemistry letters (2008-05-16)
Mark T Bilodeau, Adrienne E Balitza, Jacob M Hoffman, Peter J Manley, Stanley F Barnett, Deborah Defeo-Jones, Kathleen Haskell, Raymond E Jones, Karen Leander, Ronald G Robinson, Anthony M Smith, Hans E Huber, George D Hartman
RESUMO

A series of naphthyridine and naphthyridinone allosteric dual inhibitors of Akt1 and 2 have been developed. These compounds have been optimized to have potent dual activity against the activated kinase as well as the activation of Akt in cells. One molecule in particular, compound 17, has potent inhibitory activity against Akt1 and 2 in vivo in a mouse lung and efficacy in a tumor xenograft model.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Quinoxaline, ≥98%